Another small trial, the Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects with Obesity-related Heart Failure with Preserved Ejection Fraction (STEP-HFpEF) trial assesed semaglutide efficay in patients with preserved LVEF (LVEF 45%) and obesity (BMI 30 kg/m 2 )
MOTS-c is added at Week 5 at 5 mg, 2-3 times per week
Mounjaro KwikPen 2.5 mg solution for injection in pre-filled pen Summary of Product Characteristics
143 , 5160 (2014) Wheeler, M
"Now, basically, everyone's coming to the middle and asking, 'How do we responsibly cover these drugs?'" Part of responsible coverage, Inkinen said, is providing other forms of support to patients who stop using GLP-1 medications, by choice or otherwise
Dont hesitate to reach out to us with any concerns were here to help you succeed